Faith L. Charles - 30 Dec 2022 Form 3 Insider Report for CNS Pharmaceuticals, Inc. (CNSP)

Role
Director
Signature
/s/ Christopher Downs, Attorney-in-fact
Issuer symbol
CNSP
Transactions as of
30 Dec 2022
Net transactions value
$0
Form type
3
Filing time
04 Jan 2023, 15:01:21 UTC
Previous filing
28 Sep 2022
Next filing
16 Jun 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney